SOL Global invests in OG DNA Genetics

On Dec. 12, 2018, SOL Global Investments Corp. announced an investment in OG DNA Genetics Inc. ("DNA Genetics") in which  SOL Global acquired an approximate 8% stake for $13.3 million.

DNA Genetics is recognized worldwide for its highly selective, genetics-based approach to cannabis cultivation. DNA Genetics is established in the US cannabis marketplace, cooperating two million square feet of medical canopy in California, where they began developing high-quality cannabis seeds for the global market. DNA Genetics is also the exclusive provider of DNA certified products to a wholly-owned Ontario-based subsidiary which is of one of the world's largest diversified cannabis and hemp companies.

Gowling WLG was Canadian counsel to SOL Global in this investment with a team that included Peter Simeon and Josh Almario.